CN107661419A - 一种迷迭香妇科凝胶及其制备方法 - Google Patents
一种迷迭香妇科凝胶及其制备方法 Download PDFInfo
- Publication number
- CN107661419A CN107661419A CN201710967740.6A CN201710967740A CN107661419A CN 107661419 A CN107661419 A CN 107661419A CN 201710967740 A CN201710967740 A CN 201710967740A CN 107661419 A CN107661419 A CN 107661419A
- Authority
- CN
- China
- Prior art keywords
- rosemary
- root
- preparation
- finished product
- gynecological gel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 238000001879 gelation Methods 0.000 title abstract description 9
- 241001529742 Rosmarinus Species 0.000 title 1
- 244000178231 Rosmarinus officinalis Species 0.000 claims abstract description 48
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims abstract description 24
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 24
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 24
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 24
- 229940116229 borneol Drugs 0.000 claims abstract description 24
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 24
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 24
- 229940041616 menthol Drugs 0.000 claims abstract description 24
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 22
- 238000000034 method Methods 0.000 claims abstract description 22
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims abstract description 21
- 235000006226 Areca catechu Nutrition 0.000 claims abstract description 19
- 235000016811 Biondella Nutrition 0.000 claims abstract description 19
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 19
- 244000153955 Reynoutria sachalinensis Species 0.000 claims abstract description 19
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 claims abstract description 19
- 240000007164 Salvia officinalis Species 0.000 claims abstract description 19
- 241001530209 Swertia Species 0.000 claims abstract description 19
- 239000002994 raw material Substances 0.000 claims abstract description 19
- 235000005412 red sage Nutrition 0.000 claims abstract description 19
- 244000153234 Hibiscus abelmoschus Species 0.000 claims abstract description 18
- 235000013717 Houttuynia Nutrition 0.000 claims abstract description 18
- 240000000691 Houttuynia cordata Species 0.000 claims abstract description 18
- 229910052957 realgar Inorganic materials 0.000 claims abstract description 18
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 17
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 17
- 244000301850 Cupressus sempervirens Species 0.000 claims abstract 5
- 239000000047 product Substances 0.000 claims description 27
- 239000000284 extract Substances 0.000 claims description 24
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 20
- 239000006166 lysate Substances 0.000 claims description 19
- 244000061520 Angelica archangelica Species 0.000 claims description 18
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 claims description 16
- QRYRORQUOLYVBU-VBKZILBWSA-N carnosic acid Chemical compound CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 claims description 16
- 239000011265 semifinished product Substances 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000011259 mixed solution Substances 0.000 claims description 10
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 claims description 8
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 claims description 8
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 claims description 8
- 238000000605 extraction Methods 0.000 claims description 7
- 229920002907 Guar gum Polymers 0.000 claims description 5
- 229960002154 guar gum Drugs 0.000 claims description 5
- 235000010417 guar gum Nutrition 0.000 claims description 5
- 239000000665 guar gum Substances 0.000 claims description 5
- 238000009835 boiling Methods 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 244000080767 Areca catechu Species 0.000 claims 4
- 240000000260 Typha latifolia Species 0.000 claims 4
- 241000251468 Actinopterygii Species 0.000 claims 1
- 244000025254 Cannabis sativa Species 0.000 claims 1
- 235000020995 raw meat Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 25
- 244000235603 Acacia catechu Species 0.000 abstract description 15
- 240000001398 Typha domingensis Species 0.000 abstract description 14
- 201000010099 disease Diseases 0.000 abstract description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 14
- 239000003814 drug Substances 0.000 abstract description 11
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 230000002588 toxic effect Effects 0.000 abstract description 5
- 230000001954 sterilising effect Effects 0.000 abstract description 2
- 240000002045 Guettarda speciosa Species 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 229940126672 traditional medicines Drugs 0.000 abstract 1
- 238000005303 weighing Methods 0.000 abstract 1
- 241000218691 Cupressaceae Species 0.000 description 14
- 230000008859 change Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 238000002156 mixing Methods 0.000 description 4
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 229940059082 douche Drugs 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 210000001215 vagina Anatomy 0.000 description 3
- WITLAWYGGVAFLU-UHFFFAOYSA-N 3-(6-methoxy-1,3-benzodioxol-5-yl)-8,8-dimethylpyrano[2,3-f]chromen-4-one Chemical compound C1=CC(C)(C)OC2=CC=C(C(C(C3=CC=4OCOC=4C=C3OC)=CO3)=O)C3=C21 WITLAWYGGVAFLU-UHFFFAOYSA-N 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 2
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 2
- 235000005487 catechin Nutrition 0.000 description 2
- 208000019065 cervical carcinoma Diseases 0.000 description 2
- 229950001002 cianidanol Drugs 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000003628 erosive effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000000554 physical therapy Methods 0.000 description 2
- 230000000644 propagated effect Effects 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 235000010894 Artemisia argyi Nutrition 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000186227 Corynebacterium diphtheriae Species 0.000 description 1
- 240000005636 Dryobalanops aromatica Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010058821 Genital tract inflammation Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- MXTLAHSTUOXGQF-UHFFFAOYSA-O Jatrorrhizine Chemical compound COC1=CC=C2C=C3C(C=C(C(=C4)O)OC)=C4CC[N+]3=CC2=C1OC MXTLAHSTUOXGQF-UHFFFAOYSA-O 0.000 description 1
- 241000218378 Magnolia Species 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000244269 Peucedanum Species 0.000 description 1
- RBBVPNQTBKHOEQ-KKSFZXQISA-O Phellodendrine Chemical compound C1CC2=CC(OC)=C(O)C=C2[C@H]2[N@+]1(C)CC(C=C(C(=C1)O)OC)=C1C2 RBBVPNQTBKHOEQ-KKSFZXQISA-O 0.000 description 1
- 208000035415 Reinfection Diseases 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241001312524 Streptococcus viridans Species 0.000 description 1
- 244000134857 Typha capensis Species 0.000 description 1
- 201000003761 Vaginal carcinoma Diseases 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 244000030166 artemisia Species 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 210000005002 female reproductive tract Anatomy 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 230000005669 field effect Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- XDROKJSWHURZGO-UHFFFAOYSA-N isopsoralen Natural products C1=C2OC=CC2=C2OC(=O)C=CC2=C1 XDROKJSWHURZGO-UHFFFAOYSA-N 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- MLMVLVJMKDPYBM-UHFFFAOYSA-N pseudoisopsoralene Natural products C1=C2C=COC2=C2OC(=O)C=CC2=C1 MLMVLVJMKDPYBM-UHFFFAOYSA-N 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 210000005000 reproductive tract Anatomy 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 239000006163 transport media Substances 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 230000005186 women's health Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
- A61K36/515—Gentiana
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Inorganic Chemistry (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种迷迭香妇科凝胶及其制备方法,其中制备迷迭香妇科凝胶的原料按重量配比为:迷迭香180‑210g、虎杖50‑70g、黄柏80‑110g、白芷40‑60g、丹参40‑60g、当归20‑40g、红花10‑30g、龙胆草20‑40g、鱼腥草40‑60g、蒲黄20‑30g、儿茶10‑20g、冰片10‑20g、雄黄10‑20g、麝香5‑10g及薄荷脑5‑10g,将上述中药经称取、提取、溶解、煎煮、制备、添加稠和剂及灭菌一系列过程制成迷迭香妇科凝胶。本产品以多种纯天然中药配伍熬制而成,不仅对人体的毒副作用小,而且对妇科疾病的治疗有很好的治疗效果。
Description
技术领域
本发明涉及妇科生殖道用药领域,更具体地说是涉及一种迷迭香妇科凝胶及其制备方法。
背景技术
经调查显示:女性妇科疾病成为困扰女性健康的重要疾病之一,主要包括:生殖道炎症、异味、宫颈糜烂、宫颈癌等。这些疾病不仅会影响女性的生育能力,还会对女性身心健康带来巨大伤害。
现有技术中,妇科疾病的治疗手段主要包括:西药和抗生素治疗、物理疗法、手术治疗三大类。其中,西药和抗生素治疗是最常用的手段,但是此种方法极易破坏女性生殖道的菌群和酸碱平衡,造成免疫力低下、炎症延绵不断复发感染的情况;物理疗法是相对健康的治疗手段,包括电熨、激光、冷冻等,长期接触会造成宫颈分泌腺闭锁,使宫颈粘液发生改变而患不孕症,也易造成分娩时宫颈扩张障碍;而手术治疗则是最简单的治疗方法,也是对身体伤害最大的治疗手段,除非特殊情况,否则不建议进行手术治疗。
因此,如何提供一种对女性身体副作用小的妇科疾病用药是本领域技术人员亟需解决的问题。
发明内容
有鉴于此,本发明提供了一种迷迭香妇科凝胶及其制备方法,本产品能解决西药抗生素和激素对人体产生毒副作用的问题,同时对治疗妇科疾病有很好的疗效。
为了实现上述目的,本发明采用如下技术方案:
一种迷迭香妇科凝胶及其制备方法,它由下述重量比的原料构成:
迷迭香180-210g、虎杖50-70g、黄柏80-110g、白芷40-60g、丹参40-60g、当归20-40g、红花10-30g、龙胆草20-40g、鱼腥草40-60g、蒲黄20-30g、儿茶10-20g、冰片10-20g、雄黄10-20g、麝香5-10g、薄荷脑5-10g。
作为本发明优选的技术方案,各原料的最优配比为:迷迭香200g、虎杖60g、黄柏100g、白芷50g、丹参50g、当归30g、红花20g、龙胆草30g、鱼腥草50g、雄黄15g、蒲黄25g、儿茶15g、冰片12g、麝香6g、薄荷脑8g。
一种迷迭香妇科凝胶及其制备方法,由以下过程制备而成:
1)称取:按照一定重量配比称取以下原料:迷迭香、虎杖、黄柏、白芷、丹参、当归、红花、龙胆草、鱼腥草、雄黄、蒲黄、儿茶、冰片、麝香及薄荷脑,并且将上述原料称量完毕后单独分包,待用;
2)提取:将步骤(1)称取的所述迷迭香研磨成粉,研磨细度为350-451目,向其中加入500-700mL的水,煮沸后先大火煎熬10-20min,然后改小火煎熬25-35min,得到迷迭香的煎煮液,然后于迷迭香煎煮液中提取迷迭香酸和鼠尾草酸的混合提取液;
3)溶解:将步骤(1)称取的所述冰片和所述薄荷脑混合均匀后放入容器中,并向容器内加入溶解液进行溶解得到混合溶液;其中,溶解液:冰片和薄荷脑的总质量之比为10-20:1
4)煎煮:将步骤(1)称取的所述虎杖、所述黄柏、所述白芷、所述丹参、所述当归、所述红花、所述龙胆草、所述鱼腥草及所述蒲黄混合均匀后,置于2500-3500mL的水中煎煮20-40min,过滤取汁;并且将取得的滤汁以小火煎煮浓缩成380-420mL的汁液,停止操作;
5)制备:将步骤1)称取的所述雄黄、所述麝香和所述儿茶研磨成粉并向其中加入步骤(2)中的混合提取液25-35mL、步骤3)中的混合溶液15-25mL、步骤4)中的汁液380-420mL,搅拌均匀得到半成品;
6)添加稠和剂:向步骤5)的半成品中加入稠和剂制成成品;其中稠和剂和半成品的质量之比是10:120-140;
7)灭菌并包装:将步骤6)中的成品于121℃下灭菌20min并将成品进行封装。
作为本发明优选的技术方案,步骤2)中所述混合提取液的提取方法包括超声波提取。
作为本发明优选的技术方案,步骤3)中所述溶解液包括乙醇。
作为本发明优选的技术方案,步骤6)中所述稠和剂包括瓜尔胶。
经由上述技术方案可知,与现有技术相比,首先,本发明公开了以纯天然草药治疗妇科疾病的技术方案,其中,迷迭香具有镇静安神、醒脑作用,对消化不良和胃痛均有一定疗效,也可用于治疗失眠、心悸、头痛、消化不良等多种疾病;虎杖味微苦,性微寒,对治疗女性痛经、闭经等妇科疾病具有一定的功效;黄柏的有效成分为小檗碱,另含黄柏碱、木兰花碱、药根碱等,这几种化学成分对金黄色葡萄球菌、肺炎球菌、白喉杆菌、草绿色链球菌、痢疾杆菌、溶血性链球菌、脑膜炎球菌、霍乱弧菌、炭疽杆菌均有较强的抑制作用,以此达到阴道杀菌的目的;白芷中的提取物对大肠杆菌及格兰氏阳性细菌有抑制作用,且其中的前胡素和自当归素具有对Hela细胞的细胞毒作用,因此具有抗癌的作用;红花、丹参和当归三味中药配伍对治疗阴虚血亏,痛经、月经排出不畅等症状具有很好的疗效,且还具有活血化瘀的功效;龙胆草和鱼腥草具有清热解毒,消肿止痛的功效;雄黄对细菌、真菌及肿瘤细胞具有抑制作用,且对阴道癌和宫颈癌的治疗有一定的效果;蒲黄可止血,化瘀,也可治疗痛经、闭经等症状;儿茶中含有大量的儿茶素,儿茶素具有较强的抗氧化作用,因此可促进人体的新陈代谢及细胞的再生,并且能够抑制的癌细胞的增殖;冰片中含有龙脑香和艾脑,能够清热解毒镇痛;薄荷脑对消炎和镇痛起到辅助的作用。
其次,对原料进行粉碎再从中提取有效化学成分,使提取过程更加方便快捷,节省了熬制的时间;而且迷迭香酸和鼠尾草酸的提取方式采用超声波法提取,根据惠更斯波动原理,超声波在其传播的波阵面上将引起迷迭香酸和鼠尾草酸介质的运动,使介质质点运动获得巨大的加速度和动能,而且,超声波在液体介质中传播产生特殊的“空化效应”,“空化效应”不断产生压力为上千个大气压的微气穴并不断“爆破”,从而产生微观上的强大冲击波作用在煎煮液中,使其中迷迭香酸和鼠尾草酸被“轰击”逸出,从而使有效成分更容易提取。
综上所述,中药材中的药效物质在超声波场作用下不但作为介质质点获得自身的巨大加速度和动能,而且通过“空化效应”获得强大的外力冲击,所以能高效率并充分分离出来。溶解液采用乙醇,乙醇为有机溶剂,能加速药物中有效成分的萃取。由于本产品的存在形式在凝胶,因此需要加入稠和剂,使产品变为固体,便于保存和运输;在药品封装前对其灭菌,保证了药物的安全性。
综上所述,本发明提供的一种迷迭香妇科凝胶及其制备方法,采用纯天然草药配伍熬合而成,不仅对人体的副作用小,而且对治疗妇科疾病有很好的疗效。
具体实施方式
为了进一步阐述本发明的有益效果,申请人以以下三种实施方式为例进行验证:
具体实施方式一:
一种迷迭香妇科凝胶及其制备方法,它有下述最优重量比的原料构成:
迷迭香200g、虎杖60g、黄柏100g、白芷50g、丹参50g、当归30g、红花20g、龙胆草30g、鱼腥草50g、雄黄15g、蒲黄25g、儿茶15g、冰片12g、麝香6g、薄荷脑8g。
作为本发明最优的实施方式,本产品由以下过程制备而成:
1)称取:按照一定重量配比称取以下原料:迷迭香、虎杖、黄柏、白芷、丹参、当归、红花、龙胆草、鱼腥草、雄黄、蒲黄、儿茶、冰片、麝香及薄荷脑,并且将上述原料称量完毕后单独分包,待用;
2)提取:将步骤(1)称取的迷迭香研磨成粉,研磨细度最佳为400目,并向其中加入600mL的水,煮沸后先大火煎熬15min,然后改小火煎熬30min,得到迷迭香酸和鼠尾草酸的混合提取液;
3)溶解:将步骤(1)称取的冰片和薄荷脑混合均匀后放入容器中,并向容器内加入溶解液进行溶解得到混合溶液;其中,溶解液:冰片和薄荷脑的总质量之比为15:1
4)煎煮:将步骤(1)称取的所虎杖、黄柏、白芷、丹参、当归、红花、龙胆草、鱼腥草及蒲黄混合均匀后,置于3000mL的水中煎煮30min,过滤取汁;并将取得的滤汁以小火煎煮浓缩成400mL的汁液,停止操作;
5)制备:将步骤1)称取的雄黄、麝香和儿茶研磨成粉并向其中加入步骤(2)中的混合提取液30mL、步骤3)中的混合溶液20mL、步骤4)中的汁液400mL,搅拌均匀得到半成品;
6)添加稠和剂:向步骤5)的半成品中加入稠和剂制成成品;其中稠和剂和半成品的质量之比是10:130;
7)灭菌并包装:将步骤6)中的成品于121℃下灭菌20min并将成品进行封装。
作为本发明优选的实施例,步骤2)中的混合提取液的提取方法包括超声波提取。
作为本发明优选的实施例,步骤3)中的溶解液包括乙醇。
作为本发明优选的实施例,步骤6)中的稠和剂包括瓜尔胶。
将以上方法制备的迷迭香妇科凝胶作用于30名志愿者,这30名志愿者均患有不同程度的宫颈糜烂,且患病史长达5年以上,使用方法:使用前用温开水300mL加3g食盐完全溶解,然后将溶解液装入一次性阴道冲洗器中,采用蹲式位,将阴道冲洗器插入阴道内冲洗干净后,人体平卧,将凝胶推注器缓缓送入阴道8cm深处,然后将凝胶一次性推入,每天两次,7天为一个疗程。统计情况如下:
表一
由以上数据可知,本产品的见效率高达90%甚至100%,且无明显的毒副作用,因此本品对治疗妇科疾病有显著的疗效。
具体实施方式二:
一种迷迭香妇科凝胶及其制备方法,它有下述较优重量比的原料构成:
迷迭香180g、虎杖50g、黄柏80g、白芷40g、丹参40g、当归20g、红花10g、龙胆草20g、鱼腥草40g、雄黄10g、蒲黄20g、儿茶10g、冰片10g、麝香5g、薄荷脑5g。
作为本发明最优的实施方式,本产品由以下过程制备而成:
1)称取:按照一定重量配比称取以下原料:迷迭香、虎杖、黄柏、白芷、丹参、当归、红花、龙胆草、鱼腥草、雄黄、蒲黄、儿茶、冰片、麝香及薄荷脑,并且将上述原料称量完毕后单独分包,待用;
2)提取:将步骤(1)称取的迷迭香研磨成粉,研磨细度最佳为400目,并向其中加入500mL的水,煮沸后先大火煎熬10min,然后改小火煎熬25min,得到迷迭香酸和鼠尾草酸的混合提取液;
3)溶解:将步骤(1)称取的冰片和薄荷脑混合均匀后放入容器中,并向容器内加入溶解液进行溶解得到混合溶液;其中,溶解液:冰片和薄荷脑的总质量之比为10:1
4)煎煮:将步骤(1)称取的所虎杖、黄柏、白芷、丹参、当归、红花、龙胆草、鱼腥草及蒲黄混合均匀后,置于2500mL的水中煎煮25min,过滤取汁;并将取得的滤汁以小火煎煮浓缩成380mL的汁液,停止操作;
5)制备:将步骤1)称取的雄黄、麝香和儿茶研磨成粉并向其中加入步骤(2)中的混合提取液25mL、步骤3)中的混合溶液15mL、步骤4)中的汁液380mL,搅拌均匀得到半成品;
6)添加稠和剂:向步骤5)的半成品中加入稠和剂制成成品;其中稠和剂和半成品的质量之比是10:120;
7)灭菌并包装:将步骤6)中的成品于121℃下灭菌20min并将成品进行封装。
作为本发明优选的实施例,步骤2)中混合提取液的提取方法包括超声波提取。
作为本发明优选的实施例,步骤3)中的溶解液包括乙醇。
作为本发明优选的实施例,步骤6)中的稠和剂包括瓜尔胶。
将以上方法制备的迷迭香妇科凝胶作用于30名志愿者,这30名志愿者均患有不同程度的阴道炎,且患病史长达5年以上,使用方法:使用前用温开水300mL加3g食盐完全溶解,然后将溶解液装入一次性阴道冲洗器中,采用蹲式位,将阴道冲洗器插入阴道内冲洗干净后,人体平卧,将凝胶推注器缓缓送入阴道8cm深处,然后将凝胶一次性推入每天一次,5天为一个疗程。统计情况如下
表二
由以上数据可知,本产品的见效率高达100%,且无明显的毒副作用,因此本品对治疗妇科疾病有显著的疗效。
具体实施方式三:
一种迷迭香妇科凝胶及其制备方法,它有下述较优重量比的原料构成:
迷迭香210g、虎杖70g、黄柏110g、白芷60g、丹参40g、当归40g、红花30g、龙胆草40g、鱼腥草60g、雄黄20g、蒲黄30g、儿茶20g、冰片20g、麝香10g、薄荷脑10g。
作为本发明最优的实施方式,本产品由以下过程制备而成:
1)称取:按照一定重量配比称取以下原料:迷迭香、虎杖、黄柏、白芷、丹参、当归、红花、龙胆草、鱼腥草、雄黄、蒲黄、儿茶、冰片、麝香及薄荷脑,并且将上述原料称量完毕后单独分包,待用;
2)提取:将步骤(1)称取的迷迭香研磨成粉,研磨细度最佳为450目,并向其中加入700mL的水,煮沸后先大火煎熬20min,然后改小火煎熬35min,得到迷迭香酸和鼠尾草酸的混合提取液;
3)溶解:将步骤(1)称取的冰片和薄荷脑混合均匀后放入容器中,并向容器内加入溶解液进行溶解得到混合溶液;其中,溶解液:冰片和薄荷脑的总质量之比为20:1
4)煎煮:将步骤(1)称取的所虎杖、黄柏、白芷、丹参、当归、红花、龙胆草、鱼腥草及蒲黄混合均匀后,置于3500mL的水中煎煮35min,过滤取汁;并将取得的滤汁以小火煎煮浓缩成420mL的汁液,停止操作;
5)制备:将步骤1)称取的雄黄、麝香和儿茶研磨成粉并向其中加入步骤(2)中的混合提取液35mL、步骤3)中的混合溶液25mL、步骤4)中的汁液420mL,搅拌均匀得到半成品;
6)添加稠和剂:向步骤5)的半成品中加入稠和剂制成成品;其中稠和剂和半成品的质量之比是10:140;
7)灭菌并包装:将步骤6)中的成品于121℃下灭菌20min并将成品进行封装。
作为本发明优选的实施例,步骤2)中的混合提取液的提取方法包括超声波提取。
作为本发明优选的实施例,步骤3)中的溶解液包括乙醇。
作为本发明优选的实施例,步骤6)中的稠和剂包括瓜尔胶。
将以上方法制备的迷迭香妇科凝胶作用于30名志愿者,这30名志愿者均患有不同程度赤白带下,月经不调的症状,且患病史长达2年以上,使用方法:使用前用温开水300mL加3g食盐完全溶解,然后将溶解液装入一次性阴道冲洗器中,采用蹲式位,将阴道冲洗器插入阴道内冲洗干净后,人体平卧,将凝胶推注器缓缓送入阴道8cm深处,然后将凝胶一次性推入,每天一次,5天为一个疗程。统计情况如下:
表三
由以上数据可知,本产品的见效率高达70%,且无明显的毒副作用,因此本品对治疗妇科疾病有显著的疗效。
注:月经期间及妊娠期间应暂停使用!
本说明书中各个实施例采用递进的方式描述,每个实施例重点说明的都是与其他实施例的不同之处,各个实施例之间相同相似部分互相参见即可。对于实施例公开的装置而言,由于其与实施例公开的方法相对应,所以描述的比较简单,相关之处参见方法部分说明即可。
对所公开的实施例的上述说明,使本领域专业技术人员能够实现或使用本发明。对这些实施例的多种修改对本领域的专业技术人员来说将是显而易见的,本文中所定义的一般原理可以在不脱离本发明的精神或范围的情况下,在其它实施例中实现。因此,本发明将不会被限制于本文所示的这些实施例。
Claims (9)
1.一种迷迭香妇科凝胶,其特征在于,它由下述重量配比的原料构成:
迷迭香180-210g、虎杖50-70g、黄柏80-110g、白芷40-60g、丹参40-60g、当归20-40g、红花10-30g、龙胆草20-40g、鱼腥草40-60g、蒲黄20-30g、儿茶10-20g、冰片10-20g、雄黄10-20g、麝香5-10g、薄荷脑5-10g。
2.根据权利要求1所述的一种迷迭香凝胶,其特征在于,它由下述最优重量配比的原料构成:迷迭香200g、虎杖60g、黄柏100g、白芷50g、丹参50g、当归30g、红花20g、龙胆草30g、鱼腥草50g、雄黄15g、蒲黄25g、儿茶15g、冰片12g、麝香6g、薄荷脑8g。
3.根据任一权利要求1-2所述的一种迷迭香妇科凝胶的制备方法,其特征在于,由以下过程制备而成:
1)称取:按照一定重量配比称取以下原料:迷迭香、虎杖、黄柏、白芷、丹参、当归、红花、龙胆草、鱼腥草、雄黄、蒲黄、儿茶、冰片、麝香及薄荷脑,并且将上述原料称量完毕后单独分包,待用;
2)提取:将步骤(1)称取的所述迷迭香研磨成粉并向其中加入500-700mL的水,煮沸后先大火煎熬10-20min,然后改小火煎熬25-35min,得到迷迭香的煎煮液,然后于迷迭香煎煮液中提取迷迭香酸和鼠尾草酸的混合提取液;
3)溶解:将步骤(1)称取的所述冰片和所述薄荷脑混合均匀后放入容器中,并向容器内加入溶解液进行溶解得到混合溶液;
4)煎煮:将步骤(1)称取的所述虎杖、所述黄柏、所述白芷、所述丹参、所述当归、所述红花、所述龙胆草、所述鱼腥草及所述蒲黄混合均匀后,置于2500-3500mL的水中煎煮20-40min,过滤取汁;并且将取得的滤汁以小火煎煮浓缩成380-420mL的汁液,停止操作;
5)制备:将步骤1)称取的所述雄黄、所述麝香和所述儿茶研磨成粉并向其中加入步骤(2)中的混合提取液25-35mL、步骤3)中的混合溶液15-25mL、步骤4)中的汁液380-420mL,搅拌均匀得到半成品;
6)添加稠和剂:向步骤5)的半成品中加入稠和剂制成成品,7)灭菌并包装:将步骤6)中的成品于121℃下灭菌20min并将成品进行封装。
4.根据权利要求3所述的一种迷迭香妇科凝胶的制备方法,其特征在于,步骤2)中所述迷迭香的研磨细度为350-450目。
5.根据权利要求3所述的一种迷迭香妇科凝胶的制备方法,其特征在于,步骤2)中所述混合提取液的提取方法包括超声波提取。
6.根据权利要求3所述的一种迷迭香妇科凝胶的制备方法,其特征在于,步骤3)中所述溶解液:所述冰片和所述薄荷脑的总质量配比为10-20:1。
7.根据权利要求3所述的一种迷迭香妇科凝胶的制备方法,其特征在于,步骤3)中所述溶解液包括乙醇。
8.根据权利要求3所述的一种迷迭香妇科凝胶的制备方法,其特征在于,步骤6)中所述稠和剂和半成品的质量配比为10:120-140。
9.根据权利要求3所述的一种迷迭香妇科凝胶的制备方法,其特征在于,步骤6)中所述稠和剂包括瓜尔胶。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710967740.6A CN107661419B (zh) | 2017-10-17 | 2017-10-17 | 一种迷迭香妇科凝胶及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710967740.6A CN107661419B (zh) | 2017-10-17 | 2017-10-17 | 一种迷迭香妇科凝胶及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107661419A true CN107661419A (zh) | 2018-02-06 |
CN107661419B CN107661419B (zh) | 2020-11-03 |
Family
ID=61097760
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710967740.6A Active CN107661419B (zh) | 2017-10-17 | 2017-10-17 | 一种迷迭香妇科凝胶及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107661419B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109821006A (zh) * | 2019-04-15 | 2019-05-31 | 官成金 | 一种用于阴部的排毒凝胶及其制备方法 |
CN110652578A (zh) * | 2018-06-29 | 2020-01-07 | 重庆合钰成贸易有限公司 | 女性舒柔养护凝胶及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103550645A (zh) * | 2013-11-14 | 2014-02-05 | 林丽娟 | 一种治疗阴道炎的中药药物 |
CN103611027A (zh) * | 2013-11-27 | 2014-03-05 | 侯亭美 | 一种临床预防、护理和治疗滴虫性阴道炎的药物组合物 |
CN103638366A (zh) * | 2013-12-20 | 2014-03-19 | 滨州医学院附属医院 | 一种用于妇女带下病的中药及其制备方法 |
-
2017
- 2017-10-17 CN CN201710967740.6A patent/CN107661419B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103550645A (zh) * | 2013-11-14 | 2014-02-05 | 林丽娟 | 一种治疗阴道炎的中药药物 |
CN103611027A (zh) * | 2013-11-27 | 2014-03-05 | 侯亭美 | 一种临床预防、护理和治疗滴虫性阴道炎的药物组合物 |
CN103638366A (zh) * | 2013-12-20 | 2014-03-19 | 滨州医学院附属医院 | 一种用于妇女带下病的中药及其制备方法 |
Non-Patent Citations (1)
Title |
---|
刘玠,初李佳娃,等: "治糜灵凝胶剂的薄层色谱鉴别研究", 《现代生物医学进展》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110652578A (zh) * | 2018-06-29 | 2020-01-07 | 重庆合钰成贸易有限公司 | 女性舒柔养护凝胶及其制备方法 |
CN109821006A (zh) * | 2019-04-15 | 2019-05-31 | 官成金 | 一种用于阴部的排毒凝胶及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN107661419B (zh) | 2020-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100404054C (zh) | 一种煮散型中药抗菌消炎剂及其制备方法和应用 | |
CN103393821B (zh) | 一种治疗慢性盆腔炎的中药组合物及其制备方法 | |
CN105998972A (zh) | 一种抑菌凝胶剂 | |
CN103041367A (zh) | 一种防治阴道炎的中药复方制剂及其制备方法 | |
CN103623182B (zh) | 一种治疗妇科炎症的药物及其制备方法 | |
CN107661419A (zh) | 一种迷迭香妇科凝胶及其制备方法 | |
CN107184911A (zh) | 一种用于预防宫颈癌和治疗乳头瘤病毒(hpv)感染及阴道炎症的产品及制备方法 | |
CN102274424A (zh) | 一种生殖系统无创排毒的中药贴垫及其生产方法 | |
CN106806877A (zh) | 改善痛经中药组合物及其制备方法和功能饮料 | |
CN103520605B (zh) | 用于治疗柔嫩艾美尔球虫感染的饲料 | |
CN105125632A (zh) | 一种治疗母畜发情迟缓的中药组合物及其制备方法和用途 | |
CN110393768A (zh) | 一种母猪子宫消炎的组合中药灌注药物及其制备方法和应用 | |
CN103656048B (zh) | 用于治疗奶牛乳房炎的药物及其制备方法 | |
CN104922449A (zh) | 一种中药消毒液及其制备方法 | |
CN103599437B (zh) | 一种治疗阴道炎的中药药液 | |
CN102091303B (zh) | 一种治疗输卵管阻塞的中药丸 | |
CN108853410A (zh) | 一种用于防治妇科疾病的中药药剂及其制备方法和应用 | |
CN109248244A (zh) | 一种治疗妇科炎症的中药及其制备方法 | |
CN103735792A (zh) | 一种治疗月经不调的药物及其制备方法 | |
CN109481545A (zh) | 一种用于产后护理的中药组合物及其制备方法 | |
CN107308254A (zh) | 八正片及其制备方法 | |
CN103181964B (zh) | 治疗动物体表创伤的中药组合物及其制备方法 | |
CN105726681A (zh) | 一种治疗奶牛子宫内膜炎的注射液及其制备方法 | |
CN108542994B (zh) | 一种用于闪跌扭伤与急性劳损等腰痛的药物组合及其制备方法 | |
CN108420952A (zh) | 消炎解毒利尿汤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |